Showing results (341-350 of 574) with videos related to

Sort By:
Pageof 58
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Significance of aspergillemia in patients with cancer: a 10-year studyD P Kontoyiannis, D Sumoza, J Tarrand, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 18, 2004
The significance of blood cultures positive for emerging saprophytic moulds in cancer patientsM S Lionakis, G P Bodey, J J Tarrand, et al.
Investigational New Drugs|December 1, 1988
Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)]S P Chawla, B S Yap, D M Tenney, et al.
American Journal of Clinical Oncology|April 1, 1986
Phase I study of thymidine (dThd) and cisplatin (DDP) given in combinationD F Chiuten, M Valdivieso, J A Benvenuto, et al.
Reviews of Infectious Diseases|November 1, 1986
Trichosporon beigelii infection: a reviewJ Hoy, K C Hsu, K Rolston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastasesA Y Bedikian, T T Chen, M A Malahy, et al.
Cancer Treatment Reports|August 1, 1980
Cytotoxic chemotherapy in adrenal cortical carcinomaM M Haq, S S Legha, N A Samaan, et al.
Cancer Treatment Reports|April 1, 1983
Phase II trial of mitoxantrone in refractory acute leukemiaE H Estey, M J Keating, K B McCredie, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II clinical evaluation of AZQ in metastatic breast cancerH Y Yap, A Y Bedikian, F C Schell, et al.
Pageof 58